Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates

Nov 07, 2023

Read More

Zai Lab Announces Participation in November Investor Conferences

Oct 26, 2023

Read More

Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023

Oct 18, 2023

Read More

Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China

Sep 18, 2023

Read More

Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China

Aug 30, 2023

Read More

Zai Lab Announces Participation in September Investor Conferences

Aug 29, 2023

Read More

Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates

Aug 07, 2023

Read More

Zai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023

Jul 20, 2023

Read More